Financhill
Back

Pharming Group Vs. uniQure NV Industry Stock Comparison

Sell
42

PHAR
Pharming Group

Last Price:
7.54
Seasonality Move:
-9.32%
Sell
5

QURE
uniQure NV

Last Price:
5.34
Seasonality Move:
10.8%
Sell
42
Pharming Group (PHAR) is a Sell

Is Pharming Group a Buy, Sell or Hold?

  • The current Pharming Group [PHAR] share price is $7.59. The Score for PHAR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
5
uniQure NV (QURE) is a Sell

Is uniQure NV a Buy, Sell or Hold?

  • The current uniQure NV [QURE] share price is $5.36. The Score for QURE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • QURE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PHAR Stock Price Chart

What is Pharming Group's stock price today?

  • The Pharming Group share price today is $7.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAR is experiencing slight selling pressure.

QURE Stock Price Chart

What is uniQure NV's stock price today?

  • The uniQure NV share price today is $5.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QURE is experiencing selling pressure, which indicates risk of future bearish movement.

PHAR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 48.35 Sell
Chaikin Money Flow: -982 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.31 - 7.97) Sell
Bollinger Bands (100): (7.57 - 9.15) Sell

QURE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 37.93 Sell
Chaikin Money Flow: -389253 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.39 - 6.37) Sell
Bollinger Bands (100): (4.51 - 7.31) Sell

PHAR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.68 Sell
20-day SMA: 7.57 Buy
50-day SMA: 7.88 Sell
200-day SMA: 9.91 Sell
8-day EMA: 7.7 Sell
20-day EMA: 7.65 Sell
50-day EMA: 7.88 Sell
200-day EMA: 9.39 Sell

QURE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.56 Sell
20-day SMA: 5.68 Sell
50-day SMA: 6.82 Sell
200-day SMA: 5.85 Sell
8-day EMA: 5.56 Sell
20-day EMA: 5.79 Sell
50-day EMA: 6.12 Sell
200-day EMA: 6.71 Sell

Pharming Group Earnings Growth & PHAR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.

uniQure NV Earnings Growth & QURE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.44 per share, an increase this year of $2.09 per share, and an increase next year of $1.38 per share.

Pharming Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

uniQure NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):